Latest News and Press Releases
Want to stay updated on the latest news?
-
Irving-based U.S. Oral Surgery Management has been named to the 2025 Inc. 5000 list, which recognizes the fastest growing companies in the U.S.
-
SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024,...
-
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- As global industries turn to high-performance, lightweight and corrosion-resistant materials, the advanced ceramics and nanoceramic powders market is...
-
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Smart Medical Devices: Global Markets” is projected to grow from $87.7 billion in 2025 to $193.3 billion...
-
Austin, TX, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Air Charter Broker Market Size, Trends and Insights By Service Type (Passenger...
-
Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single...
-
ImageFIRST Launches 5th Annual HeroesFIRST Contest to Celebrate Outstanding Healthcare Professionals
King of Prussia, PA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ImageFIRST®, the leading healthcare linen services provider, announces the launch of its 5th Annual HeroesFIRST Contest, national campaign...
-
Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Nanocoatings Market Size, Trends and Insights By Product (Anti-fingerprint,...
-
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting...
-
– 94% reduction in HSV-2 shedding rate and 98% reduction in high viral load shedding rate, both statistically significant, observed in cohort evaluating 350 mg weekly oral dose compared to placebo...